[1]
Balaguragi, S.R. et al. 2025. Nilotinib In Parkinson’s Disease: A Therapeutic Pathway Yet to Be Fulfilled . Junior Researchers. 3, 2 (May 2025), 49–53. DOI:https://doi.org/10.52340/jr.2025.03.02.09.